Magnetar Financial LLC Sells 171,362 Shares of Encompass Health Corporation $EHC

Key Points

• Magnetar Financial LLC significantly reduced its stake in Encompass Health Corporation by 96.4% during the first quarter, leaving them with only 6,458 shares valued at around $654,000.
• Encompass Health recently reported a quarterly earnings per share (EPS) of $1.40, exceeding expectations and marking a 12% increase in revenue compared to the same quarter last year.
• The company declared a quarterly dividend of $0.19 per share, reflecting an increase from its previous dividend of $0.17, with a dividend yield of 0.6%.

Magnetar Financial LLC decreased its stake in shares of Encompass Health Corporation (NYSE:EHC - Free Report) by 96.4% during the 1st quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 6,458 shares of the company's stock after selling 171,362 shares during the period. Magnetar Financial LLC's holdings in Encompass Health were worth $654,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also added to or reduced their stakes in the company. OneDigital Investment Advisors LLC bought a new stake in Encompass Health during the 1st quarter worth about $263,000. GAMMA Investing LLC increased its stake in shares of Encompass Health by 21.5% in the 1st quarter. GAMMA Investing LLC now owns 2,366 shares of the company's stock valued at $240,000 after acquiring an additional 419 shares during the last quarter. Sequoia Financial Advisors LLC increased its stake in shares of Encompass Health by 6.7% in the 1st quarter. Sequoia Financial Advisors LLC now owns 2,727 shares of the company's stock valued at $276,000 after acquiring an additional 172 shares during the last quarter. Cambridge Investment Research Advisors Inc. increased its stake in shares of Encompass Health by 30.1% in the 1st quarter. Cambridge Investment Research Advisors Inc. now owns 9,597 shares of the company's stock valued at $972,000 after acquiring an additional 2,218 shares during the last quarter. Finally, Fifth Third Bancorp increased its stake in shares of Encompass Health by 88.7% in the 1st quarter. Fifth Third Bancorp now owns 4,290 shares of the company's stock valued at $434,000 after acquiring an additional 2,017 shares during the last quarter. Institutional investors and hedge funds own 97.25% of the company's stock.

Insider Activity at Encompass Health

In related news, EVP Patrick William Tuer sold 1,020 shares of the stock in a transaction on Wednesday, August 27th. The stock was sold at an average price of $123.59, for a total value of $126,061.80. Following the sale, the executive vice president owned 18,846 shares in the company, valued at approximately $2,329,177.14. This represents a 5.13% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Insiders own 2.00% of the company's stock.

Encompass Health Stock Up 0.6%

NYSE:EHC traded up $0.77 during trading hours on Thursday, reaching $124.40. 653,746 shares of the stock were exchanged, compared to its average volume of 812,053. Encompass Health Corporation has a twelve month low of $87.85 and a twelve month high of $124.68. The company has a debt-to-equity ratio of 0.76, a current ratio of 1.06 and a quick ratio of 1.06. The firm has a 50 day moving average of $116.80 and a 200 day moving average of $111.54. The stock has a market cap of $12.53 billion, a PE ratio of 24.34, a PEG ratio of 2.13 and a beta of 0.92.

Encompass Health (NYSE:EHC - Get Free Report) last released its quarterly earnings data on Monday, August 4th. The company reported $1.40 EPS for the quarter, beating the consensus estimate of $1.20 by $0.20. The company had revenue of $1.46 billion during the quarter, compared to the consensus estimate of $1.43 billion. Encompass Health had a return on equity of 17.83% and a net margin of 9.22%.The firm's revenue for the quarter was up 12.0% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $1.11 EPS. Encompass Health has set its FY 2025 guidance at 5.120-5.340 EPS. On average, equities analysts expect that Encompass Health Corporation will post 4.8 earnings per share for the current year.

Encompass Health Increases Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, October 15th. Stockholders of record on Wednesday, October 1st will be issued a $0.19 dividend. This represents a $0.76 annualized dividend and a dividend yield of 0.6%. The ex-dividend date of this dividend is Wednesday, October 1st. This is a boost from Encompass Health's previous quarterly dividend of $0.17. Encompass Health's payout ratio is currently 14.87%.

Wall Street Analyst Weigh In

EHC has been the subject of a number of recent analyst reports. UBS Group upped their price target on Encompass Health from $130.00 to $140.00 and gave the company a "buy" rating in a research note on Wednesday, August 6th. Stephens upgraded Encompass Health from an "overweight" rating to a "strong-buy" rating and set a $135.00 price objective for the company in a research report on Thursday, June 5th. Truist Financial boosted their price objective on Encompass Health from $135.00 to $140.00 and gave the company a "buy" rating in a research report on Thursday, August 14th. Wall Street Zen lowered Encompass Health from a "strong-buy" rating to a "buy" rating in a research report on Friday, June 6th. Finally, KeyCorp boosted their price objective on Encompass Health from $122.00 to $135.00 and gave the company an "overweight" rating in a research report on Tuesday, May 27th. One analyst has rated the stock with a Strong Buy rating and six have issued a Buy rating to the company's stock. According to MarketBeat, the stock has an average rating of "Buy" and an average price target of $134.00.

Encompass Health Profile

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.